Page 2 - Attack Points News Today

Point. senator republicans oppose a $35 cap on insulin for private insurance. these are all sort of easy talking and attack points for them when they go back to their districts. >> and so what is the republican answer? is it just -- well, joe bidens president and inflations bad and so dont look over here? >> i mean, its a little bit of joe bidens president and inflations bad. its a little bit of this is really not going to help at all with the inflation problem and government spending. i think t...

Hawthorne, Calif. (May 18, 2022) – Summers on the way, but the Dueling actions already heating up! Konami Digital Entertainment, Inc. (KONAMI) is celebrating...

Konami took a moment to reveal multiple products coming out over the next couple of months for the Yu-Gi-Oh! Trading Card Game.

In ukraine, the siege of mariupol has trapped tens of thousands of people without food, water, or medicine. residents are struggling to survive under constant threat of bombardment. and one man who managed to escape. >> the city of mariupol is almost totally destroyed. and its ashes, or at least 100,000 people trapped, and trying to stay alive. but its fear that it could be far more than that the city is surrounded, and the bombs dropped day and night. escaping from here on foot scenes on unfath...

Hawthorne, Calif. (September 29, 2021) – School is back in session, and for Duelists everywhere its time for some higher learning! This Fall, Konami Digital...

- Progressionsfreies Überleben (PFS) unter Derazantinib-Monotherapie auf acht Monate verlängert Basel, 17. September 2021 Basilea Pharmaceutica AG (SIX: BSLN) gab heute die Veröffentlichung

Die befragten Test-Kunden haben ein Problem mit Personal und Sicherheit.

Forscher haben neue genetische Risikofaktoren für Osteoarthritis gefunden und neue Angriffspunkte für die Behandlung von Arthrose entdeckt.

Das c’t-Sonderheft Daten schützen 2021 gibt Know-how zum vertraulichen Kommunizieren, datensparsamen Surfen und zum Schutz der digitalen Identität an die Hand.

Das Tübinger Start-up Unternehmen HepaRegeniX hat vor kurzem mit der klinischen Phase I Studie begonnen, um die Verträglichkeit eines neuartigen Medikamentes gegen Lebererkrankungen an gesunden Pr ...